Dr Miele Cosmed Group (WAR:DMG) Piotroski F-Score: 5 (As of Jun. 29, 2026) — Near Median


WAR:DMG Dr Miele Cosmed Group SA WAR:DMG
70 GF Score
Price zł2.31
GF Value zł3.84
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dr Miele Cosmed Group Piotroski F-Score?

Dr Miele Cosmed Group WAR:DMG 70 Piotroski F-Score is 5 as of Jun. 29, 2026, which is at its 10-year median of 5.00. GuruFocus rates WAR:DMG with a GF Score™ of 70/100 and a GF Value™ of zł3.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,909 Consumer Packaged Goods companies, Dr Miele Cosmed Group ranks better than 51.91% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dr Miele Cosmed Group has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Dr Miele Cosmed Group's Piotroski F-Score or its related term are showing as below:

WAR:DMG' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Dr Miele Cosmed Group was 9. The lowest was 3. And the median was 5.

Dr Miele Cosmed Group  (WAR:DMG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Dr Miele Cosmed Group Piotroski F-Score Related Terms


Dr Miele Cosmed Group Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Dr Miele Cosmed Group's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Miele Cosmed Group Piotroski F-Score Chart

Dr Miele Cosmed Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 8.00 9.00 5.00

Dr Miele Cosmed Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.00 6.00 5.00 5.00 5.00

WAR:DMG vs PG, CL, KVUE: Piotroski F-Score Comparison

For the Household & Personal Products subindustry, Dr Miele Cosmed Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Miele Cosmed Group Piotroski F-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Dr Miele Cosmed Group's Piotroski F-Score falls into.


WAR:DMG
70GF Score
Dr Miele Cosmed Group SA WAR:DMG
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 4.188 + 5.776 + 2.282 + 3.984 = zł16.2 Mil.
Cash Flow from Operations was 11.166 + 7.582 + 18.787 + -2.697 = zł34.8 Mil.
Revenue was 126.436 + 131.609 + 123.465 + 118.046 = zł499.6 Mil.
Gross Profit was 52.706 + 53.446 + 53.989 + 52.427 = zł212.6 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(423.889 + 430.867 + 437.688 + 425.827 + 441.252) / 5 = zł431.9046 Mil.
Total Assets at the begining of this year (Mar25) was zł423.9 Mil.
Long-Term Debt & Capital Lease Obligation was zł9.7 Mil.
Total Current Assets was zł136.7 Mil.
Total Current Liabilities was zł138.8 Mil.
Net Income was 10.401 + 12.126 + 6.796 + 7.447 = zł36.8 Mil.

Revenue was 124.077 + 131.888 + 120.291 + 122.703 = zł499.0 Mil.
Gross Profit was 53.143 + 56.563 + 50.35 + 52.662 = zł212.7 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(394.965 + 412.193 + 414.249 + 404.839 + 423.889) / 5 = zł410.027 Mil.
Total Assets at the begining of last year (Mar24) was zł395.0 Mil.
Long-Term Debt & Capital Lease Obligation was zł11.3 Mil.
Total Current Assets was zł144.8 Mil.
Total Current Liabilities was zł136.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dr Miele Cosmed Group's current Net Income (TTM) was 16.2. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dr Miele Cosmed Group's current Cash Flow from Operations (TTM) was 34.8. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=16.23/423.889
=0.03828833

ROA (Last Year)=Net Income/Total Assets (Mar24)
=36.77/394.965
=0.09309686

Dr Miele Cosmed Group's return on assets of this year was 0.03828833. Dr Miele Cosmed Group's return on assets of last year was 0.09309686. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Dr Miele Cosmed Group's current Net Income (TTM) was 16.2. Dr Miele Cosmed Group's current Cash Flow from Operations (TTM) was 34.8. ==> 34.8 > 16.2 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=9.728/431.9046
=0.02252349

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=11.252/410.027
=0.0274421

Dr Miele Cosmed Group's gearing of this year was 0.02252349. Dr Miele Cosmed Group's gearing of last year was 0.0274421. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=136.677/138.835
=0.98445637

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=144.763/136.231
=1.06262892

Dr Miele Cosmed Group's current ratio of this year was 0.98445637. Dr Miele Cosmed Group's current ratio of last year was 1.06262892. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Dr Miele Cosmed Group's number of shares in issue this year was 85.779. Dr Miele Cosmed Group's number of shares in issue last year was 87.339. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=212.568/499.556
=0.42551386

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=212.718/498.959
=0.42632361

Dr Miele Cosmed Group's gross margin of this year was 0.42551386. Dr Miele Cosmed Group's gross margin of last year was 0.42632361. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=499.556/423.889
=1.17850664

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=498.959/394.965
=1.26329928

Dr Miele Cosmed Group's asset turnover of this year was 1.17850664. Dr Miele Cosmed Group's asset turnover of last year was 1.26329928. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dr Miele Cosmed Group has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Dr Miele Cosmed Group (WAR:DMG) has a Piotroski F-Score of 5 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dr Miele Cosmed Group and its competitors. This is near median its historical median of 5.00. Over the past decade, Dr Miele Cosmed Group's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Dr Miele Cosmed Group ranks #918 out of 1909 companies in the Consumer Packaged Goods industry, placing it in the top 48.1%.
Is Dr Miele Cosmed Group's Piotroski F-Score too high?
Dr Miele Cosmed Group's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Dr Miele Cosmed Group's value of 5 is 0% at this industry median. Based on the distribution chart, Dr Miele Cosmed Group ranks #918 out of 1909 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's Piotroski F-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Miele Cosmed Group ranks #918 out of 1909 companies for Piotroski F-Score. This puts Dr Miele Cosmed Group in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Dr Miele Cosmed Group's value of 5 is 0% at this benchmark. Historically, Dr Miele Cosmed Group's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Dr Miele Cosmed Group has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,909 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Miele Cosmed Group's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dr Miele Cosmed Group and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Miele Cosmed Group's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Miele Cosmed Group (WAR:DMG) is currently considered Significantly Undervalued. The stock's GF Value™ is zł3.84, compared to a current price of zł2.31 — trading 39.8% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Consumer Packaged Goods industry median of 5.00. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Dr Miele Cosmed Group (WAR:DMG), the current Piotroski F-Score is 5 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Miele Cosmed Group (WAR:DMG) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued. The current stock price of zł2.31 is trading 39.8% below its estimated GF Value™ of zł3.84. GuruFocus considers Dr Miele Cosmed Group to be Significantly Undervalued.

Key valuation signals for WAR:DMG:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: zł3.84 vs. price of zł2.31 (39.8% below fair value)
  • GF Score™: 70/100 with 3 warning signs
  • Industry Position: 0% at the Consumer Packaged Goods median (#918 of 1909)

No single metric tells the full story. See the WAR:DMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Miele Cosmed Group Business Description

Address Ulica Wielkopolska 3, Radom, POL, 26-600
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score

Get the complete analysis for WAR:DMG

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.31
Price
zł3.84
GF Value